109 related articles for article (PubMed ID: 1937985)
1. Exercise cardiovascular responses to gallopamil in ischemic heart disease.
Terrosu P; Ibba GV; Pes R; Contini GM; Delpini A; Franceschino V; Fantoccoli D; Magri M
Int J Cardiol; 1991 Oct; 33(1):75-81. PubMed ID: 1937985
[TBL] [Abstract][Full Text] [Related]
2. Gallopamil and diltiazem: a double-blind, randomized, cross-over trial in effort ischaemia.
Marraccini P; Orsini E; Brunelli C; Nassi G; Ghigliotti G; Iannetti M; Caponnetto S; L'Abbate A
Eur Heart J; 1992 Mar; 13(3):404-10. PubMed ID: 1597229
[TBL] [Abstract][Full Text] [Related]
3. [Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
Zenker GD; Rödl S; Genger K
Z Kardiol; 1989; 78 Suppl 5():94-7. PubMed ID: 2698570
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
[TBL] [Abstract][Full Text] [Related]
6. Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
Zehender M; Kosscheck U; Hohnloser S; Weiss C; Meinertz T; Just H
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S57-63. PubMed ID: 1284158
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine.
Lazzeroni E; Morozzi L; Campana M; Botti G
Eur Heart J; 1992 Apr; 13(4):526-30. PubMed ID: 1600993
[TBL] [Abstract][Full Text] [Related]
8. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
[TBL] [Abstract][Full Text] [Related]
9. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
[TBL] [Abstract][Full Text] [Related]
11. Clinical and hemodynamic effects of long-term administration of gallopamil in patients with coronary artery disease and normal or impaired left ventricular function.
Tartagni F; Maiello L; Marchetti G; Dondi M; Franchi R; Monetti N; Magnani B
Am J Cardiol; 1989 Feb; 63(5):291-5. PubMed ID: 2913730
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
Loskot F; Novotny P; Sucic P; Schneider G
Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
[TBL] [Abstract][Full Text] [Related]
13. [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Hopf R; Fleischer K; Forster A; Mohler C; Schulz PC; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 5():69-76. PubMed ID: 2698566
[TBL] [Abstract][Full Text] [Related]
14. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
Kottkamp H; Gülker H; Emmerich K; Koch HP; Minge C
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S88-94. PubMed ID: 1284163
[TBL] [Abstract][Full Text] [Related]
16. [Effect of intravenous diltiazem on stress-induced myocardial ischemia (study of hemodynamics and reproducibility of repeated studies].
Schnellbacher K; Hirsch F; Stengele E; Roskamm H
Z Kardiol; 1988 Jan; 77(1):36-43. PubMed ID: 3284218
[TBL] [Abstract][Full Text] [Related]
17. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
Zebe H
Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
[TBL] [Abstract][Full Text] [Related]
18. Dose response effects of diltiazem on treadmill tolerance in chronic stable angina: a randomized double-blind, placebo-controlled crossover trial.
McCans JL
Can J Cardiol; 1985 Jan; 1(1):17-22. PubMed ID: 3902176
[TBL] [Abstract][Full Text] [Related]
19. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Hopf R; Drews H; Kaltenbach M
Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris.
Khurmi NS; O'Hara MJ; Bowles MJ; Subramanian VB; Raftery EB
Am J Cardiol; 1984 Mar; 53(6):684-8. PubMed ID: 6367415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
